Whitefort Capital Management, LP

Name: Whitefort Capital Management, LP 13F holdings, Q3 2025
Creator: Whitefort Capital Management, LP
Published: 2025-11-14

Q2 2026Q1 2026Q4 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024

In its 13F for Q3 2025 (holdings as of September 30, 2025, filed November 14, 2025), Whitefort Capital Management, LP reported 14 stock positions worth $287.4 million. Its top holding was Arbutus Biopharma (ABUS) at 21.1% of the portfolio, followed by Roivant Sciences (ROIV, 18.6%) and Genworth Financial (GNW, 11.5%). Compared with Q2 2025, it opened 2 new positions, sold out of 2, added to 5 and reduced 3. The biggest buy was a new position in Bally's (BALY) and the biggest sale Joyy Inc.-ADR (JOYY, shares −56%).

Most Recent 13F: Q2 2026
Location: NEW YORK, NY
CIK: 0001884931
Portfolio Value: $287.4M (Q3 2025)
SEC Filing: 0001013594-25-001427 ↗ filed Nov 14, 2025

Holdings Value

Holdings 14 stocks · $287.4M


ABUS Arbutus Biopharma Corp.	21.08%	13,343,228	$60.6M	No change
ROIV Roivant Sciences Ltd.	18.59%	3,532,000	$53.4M	Reduce -9.0%
GNW Genworth Financial Inc.	11.46%	3,701,960	$32.9M	Add +14.9%
JOYY Joyy Inc.-ADR	8.26%	404,944	$23.7M	Reduce -55.7%
OABI Omniab Inc.	7.92%	14,223,658	$22.8M	Add +38.9%
CDZI Cadiz Inc.	6.55%	3,986,822	$18.8M	No change
BALY Bally's Corp.	5.19%	1,343,243	$14.9M	New
TDAY USA Today Co. Inc. filed as GANNETT CO INC	5.15%	3,585,406	$14.8M	Add +34.2%
LQDA Liquidia Corp.	4.81%	607,409	$13.8M	Reduce -54.4%
SGRY Surgery Partners Inc.	2.79%	371,000	$8.0M	No change
IWM iShares Russell 2000 ETF	2.78%	33,000	$8.0M	New
OPK Opko Health Inc.	2.64%	4,900,000	$7.6M	Add +176.2%
KG Kestrel Group	1.53%	160,916	$4.4M	Add +57.4%
VATE Innovate Corp.	1.26%	743,000	$3.6M	No change

Options reported separately and not counted above: SPY puts ($26.6M), GLD calls ($9.6M).

Other holdings (2): bonds, preferreds, convertibles and warrants · $14.6M (not counted above)

Security	Class	Shares / Principal	Value	Change
OPKO HEALTH INC (OPK 3.75 01/15/29)	NOTE 3.750% 1/1 · principal	9,350,000	$14.4M	No change
NNAVW Nextnav Inc.	*W EXP 99/99/999	47,264	$256K	No change

Total filed on the 13F, all lines: $302.1M.

Portfolio Sells Q2 2025 → Q3 2025


JOYY Joyy Inc.-ADR	Reduce -55.7%	8.26%	−11.23
GSL Global Ship Lease Inc. Class A	Sold out	0.00%	−3.90
LQDA Liquidia Corp.	Reduce -54.4%	4.81%	−2.14
TRINITY BIOTECH INVT LTD	Sold out	0.00%	−0.02
ROIV Roivant Sciences Ltd.	Reduce -9.0%	18.59%	+0.29

Portfolio Buys Q2 2025 → Q3 2025


BALY Bally's Corp.	New	5.19%	+5.19
IWM iShares Russell 2000 ETF	New	2.78%	+2.78
OPK Opko Health Inc.	Add +176.2%	2.64%	+1.66
TDAY USA Today Co. Inc.	Add +34.2%	5.15%	+1.15
GNW Genworth Financial Inc.	Add +14.9%	11.46%	+0.97
OABI Omniab Inc.	Add +38.9%	7.92%	+0.46
KG Kestrel Group	Add +57.4%	1.53%	+0.39

Options Activity Q2 2025 → Q3 2025


SPY SS SPDR S&P 500 ETF Trust-US	put	New	40,000	$26.6M

Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.

Notes & Other Activity Q2 2025 → Q3 2025


INNOVATE CORP (VATE 7.5 08/01/26 *)	NOTE 7.500% 8/0 · principal	Sold out	12,218,000	$6.3Mbefore exit

Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.

All Filings

Quarter	Positions	13F Reported Value	Top Holdings
Q2 2026	18	$391.6M	ABUS, ROIV, JOYY, BALY, GNW
Q1 2026	17	$316.6M	ABUS, ROIV, JOYY, SOC, GNW
Q4 2025	15	$317.7M	ABUS, ROIV, BALY, OABI, JOYY
Q3 2025	14	$287.4M	ABUS, ROIV, GNW, JOYY, OABI
Q2 2025Amended	14	$239.0M	JOYY, ROIV, ABUS, GNW, OABI
Q1 2025	11	$185.2M	ABUS, ROIV, JOYY, GNW, LQDA
Q4 2024	13	$191.5M	ABUS, ROIV, LQDA, GNW, CDZI
Q3 2024	13	$201.5M	ABUS, EDR, ROIV, JOYY, GNW
Q2 2024	16	$143.4M	ABUS, ROIV, NN, GNW, GSL
Q1 2024	13	$153.2M	GSL, ABUS, ROIV, LSXMK, GNW